1 |
Alain C, Pascal N, Valérie G, Thierry V. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target. Molecules 2021;26:4849. [PMID: 34443437 DOI: 10.3390/molecules26164849] [Reference Citation Analysis]
|
2 |
Salemi M, Lanza G, Mogavero MP, Cosentino FII, Borgione E, Iorio R, Ventola GM, Marchese G, Salluzzo MG, Ravo M, Ferri R. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease. Int J Mol Sci 2022;23:1535. [PMID: 35163455 DOI: 10.3390/ijms23031535] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Helligsoe ASL, Weile KS, Kenborg L, Henriksen LT, Lassen-ramshad Y, Amidi A, Wu LM, Winther JF, Pickering L, Mathiasen R. Systematic Review: Sleep Disorders Based on Objective Data in Children and Adolescents Treated for a Brain Tumor. Front Neurosci 2022;16:808398. [DOI: 10.3389/fnins.2022.808398] [Reference Citation Analysis]
|
4 |
Salemi M, Lanza G, Mogavero MP, Cosentino FII, Borgione E, Iorio R, Ventola GM, Marchese G, Salluzzo MG, Ravo M, Ferri R. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease. Int J Mol Sci 2022;23:1535. [PMID: 35163455 DOI: 10.3390/ijms23031535] [Reference Citation Analysis]
|
5 |
Caruso G, Torrisi SA, Mogavero MP, Currenti W, Castellano S, Godos J, Ferri R, Galvano F, Leggio GM, Grosso G, Caraci F. Polyphenols and neuroprotection: Therapeutic implications for cognitive decline. Pharmacol Ther 2021;:108013. [PMID: 34624428 DOI: 10.1016/j.pharmthera.2021.108013] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|